|
Nuchal Screening
What is Nuchal
Screening?
It is a method of screening during
early pregnancy to determine whether your baby is at
low or high risk for being affected with Down Syndrome
or certain other chromosome or heart abnormalities.
What does Nuchal Screening
involve?
The testing involves an early pregnancy
ultrasound between 11 and 14 weeks gestation to look
at the area around your baby’s neck, followed
by a blood test. At the time of this abdominal ultrasound,
an assessment of your baby’s anatomy is also performed
but this is limited because of the early gestational
age.
What is a “nuchal translucency”?
Every fetus
has some fluid present at the back of the neck. The
thickness of this fluid can be measured and is called
the nuchal translucency (NT) measurement. Fetuses affected
by Down Syndrome often have an increased NT thickness
as do some babies with other chromosome or heart abnormalities.
The NT measurement plus the blood work will determine
whether the pregnancy is “screen positive”
or “screen negative”.

The arrow
indicates the nuchal translucency.
What is “screen
negative”?
The majority of pregnancies will be
“screen negative” -- the results are reassuring
and further testing for chromosome abnormalities is
generally not advised. It is important to realize that
being “screen negative” does not alter routine
prenatal care.
What is “screen positive”?
Approximately 5% of pregnancies will
be “screen positive”. This means that the
fetus is at higher risk of having an abnormality and
that further tests will be offered, such as amniocentesis
or chorionic villus sampling (CVS). Being “screen
positive” does not mean that
the fetus has an abnormality, just that further testing
may be needed. It is important to remember that most
women that are “screen positive” actually
have normal fetuses.
How do I get my results?
The results of your screening will
be discussed with you either by telephone or in person
by Dr. Jason Hitkari. If you are “screen positive”,
counseling will be offered to help review the results
and discuss the options.
How do I arrange to have the
test done?
You may be referred
by your health-care provider (midwife, family doctor
or obstetrician), or you may refer yourself
by calling (604) 879-3038 to book a
time for the testing.
When is Nuchal Screening done?
It is important to note that testing
can only be done between 11 and 14 weeks
gestation. Booking should be done as early as possible.
If you are close to 14 weeks, we will do our best to
fit you in.
Who will be performing the
testing?
Dr. Jason Hitkari is an Obstetrician/Gynecologist
and Reproductive Endocrinology subspecialist who is
licensed by the Fetal Medicine Foundation to perform
NT measurements. He or the genetic counselor will contact
you directly with the results of your testing and provide
a copy to your health care provider.
What will my visit to Genesis
be like?
We pride ourselves on being professional,
courteous, and friendly. When you arrive at our facility,
you will be asked to fill out a short history form about
your medical and pregnancy history. You will then have
an ultrasound done by Dr. Hitkari to obtain the NT measurement,
confirm the pregnancy dates, and look at fetal anatomy.
Once this is done, a finger-prick blood sample will
be taken. The whole visit will take approximately one
hour. Analysis of the blood work will take 2-3 days.
Once those results are available, you and your health
care provider will be notified of the results.
Is that all the testing that
I will need during pregnancy?
It is very important to understand
that routine prenatal care should continue as scheduled
by your midwife, family doctor, or obstetrician. This
will include another routine and detailed ultrasound
between 18 and 20 weeks gestation. In addition, a blood
test during the second trimester measuring alpha-fetoprotein
should be completed to screen for neural tube defects.
This will be arranged by the health care provider looking
after you during the pregnancy. Any obstetric complications
that arise during your pregnancy will be managed by
your health care provider.
Back to Top
|